2 FTSE 100 world-beating income growth stocks I’d buy to hold forever

These FTSE 100 (INDEXFTSE:UKX) stocks have a track record of creating wealth for investors, that’s why they’re fantastic buy-and-hold investments says this Fool.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

If you’re looking for income stocks to add to your portfolio, then I highly recommend pharmaceutical giant AstraZeneca (LSE: AZN).

Astra’s most attractive quality is the fact that this company is a world leader in the pharmaceutical space, and is currently pushing out some of the most revolutionary treatments for cancer around.

For example, last weekend, the company revealed data at the American Society of Clinical Oncology, showing that its flagship cancer treatment, Imfinzi could prolong the lives of lung cancer patients whose disease had reached the third stage.

On top of this, today, Astra announced that its blood cancer drug, Calquence, showed meaningful improvement in patients with lymphocytic leukaemia when compared with a chemotherapy-based treatment. 

A world-leader

These positive developments only served to reinforce my view that Astra is a giant force in the battle against cancer, and the revolutionary treatment should guarantee an income stream for many years to come. Indeed, after several years of stagnation, City analysts expect the company to return to growth this year.

Analysts have pencilled in normalised earnings per share of $3.60 (283p) for 2019, putting the stock on a forward P/E of 21.2. As the company puts more treatments on the market, analysts are expecting further growth in 2020. The City has pencilled in earnings growth of 19.6% for the year, leaving the stock dealing at a 2020 P/E of 17.8.

This valuation looks a bit on the expensive side, but I think it is a price worth paying for the company’s growth and leading position in the global immuno-oncology market. On top of Astra’s growth potential, investors can also look forward to a dividend yield of 3.6%, covered 1.3 times by earnings per share, that’s before taking into account the City’s earnings growth forecasts for the next two years.

Proven value creator

The second business I’m going to profile has established itself as one of the best property companies UK investors can own over the past few years. The company I’m talking about is FTSE 100 commercial real estate REIT Segro (LSE: SGRO).

Segro owns and manages warehouse properties across the UK and Europe. Demand for these properties has boomed in line with the growing demand for online shopping, and the company has wasted no time in making the most of this opportunity.

Over the past six years, book value per share has increased by around 17% per annum as the enterprise has acquired new properties with reinvested earnings and additional cash from shareholders. And as the portfolio has grown, so has the company’s dividend.

As a REIT, Segro has to distribute the majority of its rental income from warehouse properties to investors as a property income distribution. For 2019, analysts reckon the company will distribute a total of 19.9p to shareholders, giving a dividend yield of 2.8% at the time of writing.

This level of income might not seem that attractive at first, but over the past five years, Segro’s distribution to shareholders has increased by approximately 60%. If the business continues to expand as it has done since 2013, I believe the payout will grow a further 60% over the next five years, potentially giving investors buying today a dividend yield of nearly 6%. This dividend growth potential is the reason why I’m recommending Segro as an income stock you can buy and hold forever.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves owns no share mentioned. The Motley Fool UK has recommended AstraZeneca. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

British union jack flag and Parliament house at city of Westminster in the background
Investing Articles

Labour winning the general election would be positive for UK stocks, says JP Morgan

One mega-bank thinks certain UK stocks could benefit following the 4 July election. This writer considers a FTSE share that…

Read more »

Older couple walking in park
Investing Articles

No savings at 40? Here’s how I’d aim to retire comfortably with FTSE 100 stocks

It's never too late to begin investing in FTSE 100 stocks for retirement. Royston Wild reveals three steps to help…

Read more »

Young Asian man drinking coffee at home and looking at his phone
Investing Articles

Down 17%, is National Grid’s share price a FTSE 100 bargain?

National Grid's share price has taken a battering following a multi-billion-pound rights issue and dividend rebasement. Is it now too…

Read more »

Environmental technology concept
Investing Articles

Up 150% this year! Can NVIDIA stock keep on soaring?

Christopher Ruane explains why NVIDIA stock has soared over 150% already this year, where it might be going -- and…

Read more »

Investing Articles

Down 44% in a year, here’s why the Aston Martin share price could keep struggling

Not only has the Aston Martin share price collapsed in recent years, our writer sees its current business performance as…

Read more »

Investing Articles

I’m considering these 2 high-growth stocks to buy as a technology investor

Our author thinks Kainos and Softcat could be two of Britain's best tech investments. He thinks the risks in the…

Read more »

Abstract 3d arrows with rocket
Investing Articles

A once-in-a-decade opportunity to buy these FTSE 100 growth shares before they rocket?

Our writer highlights two FTSE 100 growth stocks he thinks could seriously outperform as interest rates are cut and economic…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing For Beginners

Down 14% in a month, is this the FTSE 100’s biggest bargain right now?

Jon Smith mulls over whether he should buy one of the worst-performing FTSE 100 stocks based on it being an…

Read more »